How to Perform 3D Histology on Different Types of Tumors

  • Helmut Breuninger
  • Patrick Adam
Chapter

Abstract

3D histology is intended for tumors at difficult sites where a tissue-saving surgical technique is needed or if local R0 resection must be ensured due to the aggressive growth of the tumor (Table 8.1) [1]. Precondition for this technique is a continuous local, clinically invisible infiltration of the tumor. Therefore, the margins of the excised tumor have to be investigated histologically in order to verify total removal of the tumor. For safety reasons, it is recommendable to increase the width of the safety margins in the primary excision of the tumor relative to the overall size of the tumor. Only in more distinguished locations with important structures or for aesthetical reasons, it is recommendable to choose smaller safety margins in order to save healthy tissue. However, it is imperative that in any case, the full removal is diagnosed by the presence of histologically clear margins.

Keywords

Paraffin Imatinib Hematoxylin Eosin Dermatofibrosarcoma 

References

  1. 1.
    Keyvan N, editor. Mohs micrographic surgery. London: Springer; 2012.Google Scholar
  2. 2.
    Breuninger H, Dietz K. Prediction of subclinical tumour infiltration in basal cell carcinoma. J Dermatol Surg Oncol. 1991;17:574–8.PubMedGoogle Scholar
  3. 3.
    Breuninger H, Schaumburg-Lever G, Holzschuh J, Horny HP. Desmoplastic squamous cell carcinoma of skin and vermillion surface: a highly malignant subtype of skin cancer. Cancer. 1997;79:915–9.PubMedCrossRefGoogle Scholar
  4. 4.
    Häfner HM, Moehrle M, Eder S, Trilling B, Rocken M, Breuninger H. 3D-Histological evaluation of surgery in dermatofibrosarcoma protuberans and malignant fibrous histiocytoma: differences in growth patterns and outcome. Eur J Surg Oncol. 2008;34:680–6.PubMedCrossRefGoogle Scholar
  5. 5.
    Lichte V, Breuninger H, Metzler G, Haefner HM, Moehrle M. Acral lentiginous melanoma: conventional histology vs. three dimensional histology. Br J Dermatol. 2009;160:591–9.PubMedCrossRefGoogle Scholar
  6. 6.
    Boehringer A, Leiter U, Metzler G, Moehrle M, Garbe C, Breuninger H. Extramammary Paget’s disease: extended subclinical growth detected using three-dimensional histology in routine paraffin procedure and course of the disease. Dermatol Surg. 2011;37:1–10.CrossRefGoogle Scholar
  7. 7.
    Häfner HM, Breuninger H, Moehrle M, Trilling B, Krimmel M. 3D histology-guided surgery for basal cell carcinoma and squamous cell carcinoma: recurrence rates and clinical outcome. Int J Oral Maxillofac Surg. 2011;40:943–8.PubMedCrossRefGoogle Scholar
  8. 8.
    Woerle B, Heckmann M, Konz B. Micrographic surgery of basal cell carcinomas of the head. Recent Results Cancer Res. 2002;160:219–24.PubMedCrossRefGoogle Scholar
  9. 9.
    Brantsch KD, Meisner C, Schönfisch B, Trilling B, Wehner-Caroli J, Röcken M, et al. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. Lancet Oncol. 2008;9(8):713–20.PubMedCrossRefGoogle Scholar
  10. 10.
    Leibovitch I, Huilgol SC, Selva D, Hill D, Richards S, Paver R. Cutaneous squamous cell carcinoma treated with Mohs micrographic surgery in Australia: I. Experience over 10 years. J Am Acad Dermatol. 2005;53:253–60.PubMedCrossRefGoogle Scholar
  11. 11.
    Zollo JD, Zeitouni NC. The Roswell Parc Cancer Institute experience with extramammary Paget’s disease. Br J Dermatol. 2000;42:59–65.CrossRefGoogle Scholar
  12. 12.
    Breuninger H, Schaumburg-Lever G, Schlagenhauff B, Stroebel W, Rassner G. Patterns of local horizontal spread of melanomas. Consequences for surgery and histopathologic investigation. Am J Surg Pathol. 1999;23:1493–8.PubMedCrossRefGoogle Scholar
  13. 13.
    Cohen LM, McCall MW, Zax RH. Mohs micrographic surgery for lentigo maligna melanoma. A follow-up study. J Dermatol Surg. 1998;24:673–7.CrossRefGoogle Scholar
  14. 14.
    Moehrle M, Dietz K, Garbe C, Breuninger H. Conventional histology versus 3D-Histology in Lentigo maligna melanoma. Br J Dermatol. 2006;154:453–9.PubMedCrossRefGoogle Scholar
  15. 15.
    Jahn V, Breuninger H, Garbe C, Moehrle M. Melanoma of the ear: prognostic factors and surgical strategies. Br J Dermatol. 2006;154:310–8.PubMedCrossRefGoogle Scholar
  16. 16.
    Jahn V, Breuninger H, Garbe C, Maassen MM, Moehrle M. Melanoma of the nose: prognostic factors, three-dimensional histology, and surgical strategies. Laryngoscope. 2006;116(7):1204–11.PubMedCrossRefGoogle Scholar
  17. 17.
    Gloster HM, Harris KR, Roenigk RK. A comparison between Mohs micrographic surgery and wide surgical excision for the treatment of dermatofibrosarcoma protuberans. J Am Acad Dermatol. 1996;35:82–7.PubMedCrossRefGoogle Scholar
  18. 18.
    Hafner J, Schütz K, Morgenthaler W, Steiger E, Meyer V, Burg G. Micrographic surgery (Slow Mohs) in cutaneous sarcomas. Dermatology. 1999;198:37–43.PubMedCrossRefGoogle Scholar
  19. 19.
    Boyer JD, Zitelli JA, Brodland DG, D’Angelo G. Local control of primary Merkel cell carcinoma: review of 45 cases treated with Mohs micrographic surgery with and without adjuvant radiation. J Am Acad Dermatol. 2002;47:885–92.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London 2013

Authors and Affiliations

  • Helmut Breuninger
    • 1
  • Patrick Adam
    • 2
  1. 1.Universitätsklinikum Tübingen HautklinikTübingenGermany
  2. 2.Pathologie und Pathologische AnatomieUniversitätsklinikum TübingenTübingenGermany

Personalised recommendations